A Peptide‐Derived Aggregation‐Induced Emission Nanobioprobe: Unlocking Selective Detection of Fusobacterium nucleatum and Noninvasive Screening of Colorectal Cancer
Hongyu Liu,
No information about this author
T.-C. Wu,
No information about this author
Yunjian Yu
No information about this author
et al.
Aggregate,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 15, 2025
ABSTRACT
Colorectal
cancer
(CRC)
screening
and
early
diagnosis
is
an
effective
strategy
for
reducing
CRC
mortality.
However,
the
current
detection
methods
involve
exorbitant
costs
complex
procedures,
which
are
inconvenient
large‐scale
screening.
Given
its
high
prevalence
in
malignant
tissues
feces
of
patients,
Fusobacterium
nucleatum
(
F.
)
has
emerged
as
a
crucial
biomarker
CRC.
Herein,
we
propose
‐specific
recognition
diagnosis.
A
novel
nanobioprobe
(AIE‐Pep)
with
aggregation‐induced
emission
(AIE)
characteristics
was
synthesized
by
conjugating
red/near‐infrared
(NIR)
emissive
AIE
luminogen
(AIEgen)
FadA‐targeting
peptide
(ASANWTIQYND).
The
robust
binding
affinity
between
FadA
on
allows
AIE‐Pep
NPs
to
adhere
selectively
,
emits
strong
red/NIR
fluorescence.
In
model
orthotopic
CRC,
can
precisely
localize
around
Moreover,
demonstrated
limit
(LOD)
82.97
CFU/mL
could
significantly
differentiate
mice
from
those
normal
mice.
Overall,
this
study
presents
pivotal
approach
specifically
identifying
holds
immense
potential
Language: Английский
Tumor and intratumoral pathogen cascade-targeting photothermal nanotherapeutics for boosted immunotherapy of colorectal cancer
Youtao Xin,
No information about this author
Yunjian Yu,
No information about this author
Mengdi Wu
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
379, P. 574 - 591
Published: Jan. 24, 2025
Language: Английский
Cyclodextrin-based nanotherapeutics: A promising strategy for enhanced cancer therapy
Menglin Zhang,
No information about this author
Fanpeng Ran,
No information about this author
Yun Zhang
No information about this author
et al.
Chinese Chemical Letters,
Journal Year:
2025,
Volume and Issue:
unknown, P. 111232 - 111232
Published: April 1, 2025
Language: Английский
Light-responsive glycosidase inhibitors: Tuning enzyme selectivity and switching factors through integrated chemical and optoglycomic strategies
Bioorganic Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 108575 - 108575
Published: May 1, 2025
Language: Английский
Advanced hydrogel material for colorectal cancer treatment
Yu Guo,
No information about this author
Min Wang,
No information about this author
Yu‐Zhong Zhang
No information about this author
et al.
Drug Delivery,
Journal Year:
2024,
Volume and Issue:
32(1)
Published: Dec. 31, 2024
Colorectal
cancer
is
one
of
the
most
common
cancers
worldwide,
and
its
incidence
rates
are
increasing
every
year.
Treatments
for
CRC
include
surgical
resection,
chemotherapy,
radiotherapy,
targeted
therapy,
immunotherapy.
Although
various
agents
have
been
used
in
treatment
malignant
tumors,
they
not
as
effective
expected.
This
primarily
owing
to
lack
selectivity,
poor
solubility,
severe
side
effects
agents.
It
necessary
develop
more
efficient
drug
delivery
systems
precise
targeting
tumor
site
therapeutic
meet
clinical
needs.
A
hydrogel
a
three-dimensional
network
material
composed
crosslinked
chains
hydrophilic
or
hydrophobic
groups
polymer
backbone.
Hydrogels
possess
useful
properties
including
high
water
content,
adjustable
physical
characteristics,
elasticity,
flexibility,
reversible
swelling,
multifunctionality.
These
render
them
ideal
biomaterials
with
broad
range
applications
biomedicine
bioengineering.
In
this
review,
we
introduce
pathophysiology
current
advances
summarize
hydrogels
different
materials
well
smart
response
carriers
treatment.
We
also
analyze
unique
advantages
challenges
using
therapy.
Language: Английский
Bacteria-tumor symbiosis destructible novel nanocatalysis drug delivery systems for effective tumor therapy
Jing Zang,
No information about this author
Yin Fang,
No information about this author
Ziyuan Liu
No information about this author
et al.
Nanomedicine,
Journal Year:
2024,
Volume and Issue:
20(3), P. 305 - 318
Published: Dec. 30, 2024
Colorectal
cancer
(CRC)
is
a
significant
threat
to
human
health.
The
dynamic
equilibrium
between
probiotics
and
pathogenic
bacteria
within
the
gut
microbiota
crucial
in
mitigating
risk
of
CRC.
An
overgrowth
harmful
microorganisms
gastrointestinal
tract
can
result
an
excessive
accumulation
bacterial
toxins
carcinogenic
metabolites,
thereby
disrupting
delicate
balance
microbiota.
This
disruption
may
lead
alterations
microbial
composition,
impairment
mucosal
barrier
function,
potential
promotion
abnormal
cell
proliferation,
ultimately
contribute
progression
Recently,
research
has
indicated
that
intestinal
presence
Fusobacterium
nucleatum
(Fn)
significantly
influences
onset,
progression,
metastasis
Consequently,
interaction
CRC
cells
Fn
presents
promising
strategy
against
Nanomaterials
have
been
extensively
utilized
therapy
infection
control,
demonstrating
substantial
treating
bacteria-associated
tumors.
review
begins
by
elucidating
mechanisms
occurrence
CRC,
with
particular
emphasis
on
clarifying
intricate
relationship
Subsequently,
we
highlight
strategies
utilize
nanomaterials
disrupt
association
Overall,
this
offers
valuable
insight
guidance
for
leveraging
therapy.
Language: Английский